A drug‐repositioning screen for primary pancreatic ductal adenocarcinoma cells identifies 6‐thioguanine as an effective therapeutic agent for TPMT‐low cancer cells-Reference-Cited by-同舟云学术

A drug‐repositioning screen for primary pancreatic ductal adenocarcinoma cells identifies 6‐thioguanine as an effective therapeutic agent for TPMT‐low cancer cells

Published:2018-08-29 Issue:9 Volume:12 Page:1526-1539
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Kim Inki¹²,Choi Yeon‐Sook³,Song Jae Hwi³,Choi Eun A³,Park Sojung¹,Lee Eun Ji³,Rhee Je‐Keun⁴,Kim Song Cheol⁵,Chang Suhwan³⁶

Affiliation:

1. Convergence Medicine Research Center (CREDIT)/Biomedical Research Center Asan Institute for Life Sciences Seoul Korea

2. Department of Convergence Medicine Asan Medical Center University of Ulsan College of Medicine Seoul Korea

3. Department of Biomedical Sciences Asan Medical Center University of Ulsan College of Medicine Seoul Korea

4. Cancer Research Institute Catholic University of Korea Seoul Korea

5. Department of Surgery Asan Medical Center University of Ulsan College of Medicine Seoul Korea

6. Department of Physiology Asan Medical Center University of Ulsan College of Medicine Seoul Korea

Funder

Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea

Asan Institute for Life Sciences

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12364

Reference39 articles.

1. Phase II study of intravenous 6‐thioguanine in patients with advanced carcinoma of the pancreas;Ajani JA;Invest New Drugs,1991

2. Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts

3. A response of Panc‐1 cells to cis‐platinum, assessed with a cDNA array;Anderson KM;Anticancer Res,2002

4. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies

5. Ritonavir-Mediated Induction of Apoptosis in Pancreatic Cancer Occurs via the RB/E2F-1 and AKT Pathways

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleoside-based anticancer drugs: Mechanism of action and drug resistance;Biochemical Pharmacology;2023-09

2. Development and validation of a selenium metabolism regulators associated prognostic model for hepatocellular carcinoma;BMC Cancer;2023-05-18

3. Decoding Connectivity Map-based drug repurposing for oncotherapy;Briefings in Bioinformatics;2023-04-17

4. In situ MUC1-specific CAR engineering of tumor-supportive macrophages stimulates tumoricidal immunity against pancreatic adenocarcinoma;Nano Today;2023-04

5. The role of drug-metabolizing enzymes in synthetic lethality of cancer;Pharmacology & Therapeutics;2022-12